To aid in the identification of neutrophils, HIF1a was included as a type-marker, resulting in a single HIF1a+ cluster that was split into CD15+ neutrophils and other HIF1a+ tumor and stromal cells. This evidence concerns the gene HIF1A and neoplasm.